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Summary: A photometric inethod for the determination of phospholipase A is described, in which fatty acids
are liberated from phosphatidylcholine and measured by a discontinuous enzymatic test. Optimal test
conditions were evaluated using purified phospholipase A from human and porcine pancreas. The enzyme
activities measured in normal human sera are in the ränge of 0 to 10 U/l. Pathological values reach more
than 100 U/l. There is no correlation with the activities of lipase or amylase in cases of acute pancreatitis.
*
Photometrische Bestimmungsmethode für Phospholipase A
Zusammenfassung: Eine Methode zur photometrischen Bestimmung der Phospholipase A wird beschrieben,
bei der aus Phosphatidylcholin freigesetzte Fettsäuren mit einem diskontinuierlichen enzymatischen Test
nachgewiesen werden. Der Test wurde mit Hilfe gereinigter Phospholipase A aus dem Pankreas von Mensch
und Schwein optimiert; Der vorläufige Referenzbereich für die katalytische Aktivitätskonzentration in
menschlichen Seren liegt bei 0—10 U/l, pathologische Werte erreichen 100 U/l und mehr. Zu den Aktivitäten
von Lipase und Amylase besteht keine gesicherte Korrelation.
Introduction
Phospholipases AI and A2 liberate fatty acids from
the alpha- or beta-position of various phospholipids
such äs phosphatidylcholine or phosphatidyl-ethanol-
amine. During experimental pancreatitis, the actrv>
ties of both eiizymes are elevated in blood serum (1).
Especially the release of active phospholipase A2 into
the circulation seems to be associated with severe
complications of pancreatic diseases (2, 3). Since this
enzyme is able to split cellular and extracellular phos-
pholipids, it may destroy essential organ structures
and form cytptöxic lysocompounds. Furthermore,
the liberation of polyunsaturäted fatty acids, e. g.
arachidonic acid, may lead to formation of highly
active eicosanoid compounds.
We have developed a photometric method for the
determination of phospholipase A äs quantified by
. the overall-liberation of long-chain fatty acids from
soy-bean phosphatidylcholine. In the present paper,
this new method is described in detail. Preliminary
results have been published previously (4).
Materials and Methods
The föllowing reagents and enzymes were used in this study:
Soy-bean phosphatidylcholine (batch no. 0835674), Roth,
Karlsruhe.
Phospholipase A2 from porcine pancreas, Boehringer, Mann-
heim.
Triton X-100, Sigma, St. Louis, USA.
Test kit for the enzymatic determination of fatty acids, Wako
Chemicals, Osaka, Japan, including reagents and an oleic acid
Standard.
All other reagents were from Merck, Dannstadt.
A Substrate emulsion, containing phosphatidylcholine, buffer,
and activators was produced using a similar method to that
described by Shakir (5):
Soy-bean phospatidylcholine (0.3 g) is dissolved in 15 ml chlo-
rofonn/methanol (v/v = = 2 + 1) and 21 ml diluted Triton -
00 (5 g/l) is added. The organic solvent is removed at 37 °C
by vigorous shaking on a whirl-mix under a stream of nitrogen
until the milky emulsion becomes opalescent (5 to 10 min). The
resulting emulsion is stable for at least one week at 4 °C. For
preparation of the incubation mixture, the emulsion is diluted
at room temperature with an equal volume (21 ml) of an
appropriate buffer (see results section) containing sodium
deoxycholate (2 mmol/1). CaCl2 (340 mmol/1) (0.5 ml) is added
to give a final concentration of 4 mmol/1.
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A partially purified phospholipase prcparation was obtained
from autopsic human pancreas using the first two Steps (heat
treatment at acid pH and ammonium sulphate fractionation)
of the method described by Eskola et al. (6).
The phospholipase A assay was performed according to the
following reaction scheme:
Phosphatidylcholine -f H2O -> Fatty acid
-f Lysophosphatidylcholine
Fatty acid + ATP + CoASH -» Acyl-CoA + AMP + PPi
Acyl-CoA + O2 -» 2,3-fra/i5-Enoyl-CoA -f H2O2
H2O: -l· Chromogen -* H2O + "Red Quinone Colour"
Enzyme-containing sample (0.1 ml) is incubated with l ml phos-
phatidylcholine emulsion at 37 °C. At defmed time intervais,
0.2 ml aliquots of this mixture are transferred to a new test
tube containing 0.2 ml of a stop-reagent (0.05 mol/1 phosphate
buffer, pH 5.5 and 6 mmol/1 EDTA). Subsequently, fatty acids
are determined using the NEFA-test kit according to the manu-
facturers instructions, with an altered sample-reagent-ratio
(0.04 ml sample, 0.25 ml reagent A, 0.50 ml reagent B).
l Unit (U) was defmed s the liberation of l μιηοΐ fatty acid
per min. In order to detect the low phospholipase A activities
present in normal human sera (see results section), fatty acid
liberation was followed over l h of incubation. The absorbance
values (A) were converted into units by the formula
1.0r
(U/l) A 65 min546 nm min \46 nnJ
Catalytic activity concentrations of lipase (substrate triolein)
and amylase (substrate p-nitropheny 1-maltopentaoside and
-hexaoside) were measured using the test kits of Boehringer,
Mannheim and Behring Werke, Marburg, respectively.
Results
Evaluation of Optimal Assay Conditions
Porcine and human enzymes were incubated in the
substrate emulsion in order to evaluate optimal test
conditions. Since fatty acid liberation was taken s a
measure of phospholipase A activity, the oleic acid
Standard was used for calibration. An average molar
lineic absorbance of 1540 m2/mol was determined at
546 nm. As shown in tablel, oleic acid added to
substrate emulsions at different concentrations was
almost completely recovered.
The pH-dependency of phospholipase A activity was
tested with TRIS/HC1, TRIS/maleate, sodium phos-
phate, and sodium acetate (for preparation of buffers
see I.e. (7)), covering the r nge from pH 5.5-10
(% 1).
Tab. l. Recovery of oleic acid added to the phosphatidylcholine
emulsion.
Oleic acid (mmol/1)
Added
0
0.09
0.23
0.45
0.91
Measured
0.08 '
0.16
0.30
0.49
0.91
Expected
0.17
0.31
0.53
0.99
Fig. l. pH-optima of human and porcine pancreatic phospho^
lipase A.
left side: human enzyrae, TRIS/maleate buffer (dotted
line: TRIS/HC1 buffer)
right side: porcine enzyme, TRIS/HC1 buffer.
The pH-optimum was found to be around 8.0 for the
porcine and at 6.5 for the human enzyme using 0.1
mol/1 TRIS/HC1 and TRIS/maleate buffer (fig. 1).
Low activities were obtained with equimolar phos-
phate and citrate buffers. When 0.1 mol/1 TRIS-
maleate buffer, pH 6.5 was used instead of TRIS/
HC1 the activity of the human enzyme was about 20
percent higher and that of the porcine enzyme was
reduced to about one third. Increasing TRIS/maleate
concentrations up to 0.4 mol/1 reduced the measur-
able activity of both enzymes considerably, whereas
reductipn of buffer concentration had little effect (fig.
2). With TRIS/HC1 buffer no such concentration
dependence was evident.
The optimal concentration of deoxycholate was at-
tained at l mmol/1. Under these conditions, addition
of CaCl2 up to 6 mmol/1 did not greatly influence the
catalytic activity, probably due to the presence of
100
80
< 60
O)
ΙΛσCL
"
o
20
0.05 0.10 0.15 " 0.20
Tris/ma-leate [mal/ l ]
0.25
Fig. 2. Inhibition of human pancreatic phospholipase A by
increasing concentrations of TRIS/maleate buffer. Each
point represents the mean of 2 independent experiments.
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Fig. 3. Reactivation of phospholipase A by calcium chloride
in the presence of 2 mmol/1 EDTA.
Spontaneous hydrolysis of phosphatidylcholine emul-
sion was neglegible ("blank activity" = 0 to 3 U/l).
Within-run and day-to-day precisions were between
4 and 10 percent respectively (tab. 2).
Tab. 2. Within-run and day-to-day precision (n = 5) of the
phospholipase assay. A human pool serum was stocked
with purified porcine phospholipase A2 and stored fro-
zen at -20 °C in 0.1 ml aliquots.
Within run
Day-to-day
Mean value
(U/l)
15.8
32.5
15.4
31.0
SD
(U/l)
1.64
1.29
1.14
2.24
CV
(%)
10.4
4.0
7.4
7.2
calcium in the assay mixture (about 0.7 mmol/1). Only
in the presence of EDTA, which completely inhibited
the catalytic activity, could a clear calcium depend-
ence be demonstrated (fig. 3).
As a prelininary recommendation, the following reac-
tion mixture was chosen for the measurement of
porcine s well s human phospholipase A:
7.9 mmol/1 phosphatidylcholine, 125 mmol/1 TRIS/
HCI, pH 8.0, l mmol/1 deoxycholate, 4 mmol/1 cal-
cium Chloride, 2.5 g/l Triton X-100.
Analytical properties
The assay was linear for at least l hour (fig. 4) if the
maximal difference of absorbance did not exceed
0.15. This corfesponds to a liberation of up to 0.4
mmol/1 fatty acids in the assay mixture.
1.5r
20 40
t [min]
Fig. 4. Linearity of the phospholipase A assay. For further
details see results section.
The dotted line represents the recommended dilution
limit.
The activity concentration measured at pH 8.0 in
fasting sera of healthy volunteers was low (5.8 ± 2.9
U/l, median = 6 U/l, n = 14). Preliminary experi-
ments with sera from pancreatitis patients revealed
catalytic concentrations between 0 and 110 U/l. There
was no significant correlation with lipase or amylase
catalytic activity (fig. 5).
A typical example is given in figure 6: enzyme activi-
ties were measured in a 44 year old man who was
hospitalized because of an attack of acute necrotizing
pancreatitis. Despite surgical interventions on the lst,
18th, and 46Λ day and intensive pharmacotherapy he
died after 11 weeks of hospitalization. Amylase and
lipase activities were highest at the beginning of the
disease and feil to normal values later, while phos-
pholipase A remained elevated throughout the time
of hospitalization.
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Fig. 5. Correlation of phospholipase A activities with lipase
(crosses) and amylase activity (circles) in 176 sera of
patients with acute pancreatitis. Activities were trans-
formed to log-scales for clearness.
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Fig. 6. Activities of phospholipase A (o —o), lipase (o—o),
and amylase (x—x) in the serum of a patient who died
from an attack of acute nccrotizing pancreatitis 11
weeks after admission to the hospital. Relative activities
are expressed in terms of the respective upper limit of
the normal ränge (dotted line) for better comparability.
Discussion
The measurement of phospholipase. A activities in
human sera has been hampered so far by the lack of
suitable routine methods. Most published procedures
are time-consuming and laborious or need special
equipment and uncommon reagents. Relatively
simple titrimetric assays (8) are not sensitive enough
for serum analyses unless incubation times of up to
18 hours are applied (9).
This paper describes a photometric assay äs an al-
ternative. The new assay uses only commercially
available reagents and normal laboratory equipment.
It is sensitive enough to distinguish between normal
(up to 10 U/l) and elevated activities (up to about
130 U/l). It must be noted that the analytical impreci-
sion is relatively high (tab. 2) due to low measuring
Signals. Duplicate analyses are therefore recommend-
ed.
The test conditions which were elaborated for the
new assay are similar to those described by other
authors for pancreatic and "postheparin-"phospho-
hpase A (5, 8, 10). Lysosomal leukocyte phospho-
lipase A2 seems to be active at acid pH (11). The
activities of about 0-10 U/l, which were found in
normal human sera, are higher than those reported
by others. Vogel & Zieve (9) obtained a normal ränge
around l U/l using a titrimetric method. The mean
normal values of Miwa et al. (12) and Thuren et al
(13) were even below 0.1 U/l äs measured with an
isotopic and a fluorometric assay. These differences
are most probably due to differences in the physico-
chemical properties of phospholipid Substrates used.
Moreover, very different pH-values ranging from
pH 5 (13) to pH 9 (6, 14) have been found to be
optimal for the action of human pancreatic phospho-
lipase A2. Further studies will be needed to clarify
this discrepancy. The test conditipns given here are
suitable for the measurement of auman äs well äs
porcine phospholipase A. This is useful, since com-
mercial enzyme preparations are often of porcine
origin, and the pig is a widely used animal model for
experimental pancreatitis.
In the literature, there are some contradictory reports
äs to whether serum phospholipase A activities paral-
lel those of lipase and amylase (15) or not (13, 16).
Our data ((17), this paper) indicate that phospho-
lipase A does not necessarily behave in the same
manner äs other pancreatic enzymes. It is interesting
that the serum concentrations of the enzyme protein
of phospholipase A2, äs measured by immunological
assays, usually parallel the activities of amylase in
cases of acute pancreatitis and pancreatic cancer (18).
Since these determination methods do not distinguish
between active phospholipase and its inactive pro-
enzyme (14, 18), the following working hypothesis
may be established: In a variety of diseases where
pancreatic enzymes are released into the blood
stream, the enzyme pattern in serum resembles that
of the non-injured pancreas, i. e. amylase and lipase
are found at high catalytic concentrations, while
phospholipase A2 is predominant äs inactive proen-
zyme. In severe cases, characterized by activation of
proenzymes (2, 3), the total proportion of phospho-
lipase protein may rise less mä'rkedly than its active
form. Furthermore, phospholipases of non-pan-
creatic origin (11, 19) may interfere with either
method due to common immunological and catalytic
properties.
Several clinical studies are presently in progress to
investigate in more detail the postulated importance
and prognostic potency (2, 3, 19) of phospholipase A
activity in serum.
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